These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 21135325)

  • 21. Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies.
    Tickell A; Byng R; Crane C; Gradinger F; Hayes R; Robson J; Cardy J; Weaver A; Morant N; Kuyken W
    BMJ Open; 2020 Feb; 10(2):e033892. PubMed ID: 32075835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.
    Dunlop BW; LoParo D; Kinkead B; Mletzko-Crowe T; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
    Am J Psychiatry; 2019 Apr; 176(4):275-286. PubMed ID: 30764648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.
    Huijbers MJ; Spijker J; Donders AR; van Schaik DJ; van Oppen P; Ruhé HG; Blom MB; Nolen WA; Ormel J; van der Wilt GJ; Kuyken W; Spinhoven P; Speckens AE
    BMC Psychiatry; 2012 Aug; 12():125. PubMed ID: 22925198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mindfulness-based cognitive therapy vs. psycho-education for patients with major depression who did not achieve remission following antidepressant treatment.
    Chiesa A; Castagner V; Andrisano C; Serretti A; Mandelli L; Porcelli S; Giommi F
    Psychiatry Res; 2015 Apr; 226(2-3):474-83. PubMed ID: 25744325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission.
    Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA
    J Affect Disord; 2012 Dec; 142(1-3):77-81. PubMed ID: 22980402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.
    Zhang Z; Zhang L; Zhang G; Jin J; Zheng Z
    BMC Psychiatry; 2018 Feb; 18(1):50. PubMed ID: 29475431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.
    Kuyken W; Warren FC; Taylor RS; Whalley B; Crane C; Bondolfi G; Hayes R; Huijbers M; Ma H; Schweizer S; Segal Z; Speckens A; Teasdale JD; Van Heeringen K; Williams M; Byford S; Byng R; Dalgleish T
    JAMA Psychiatry; 2016 Jun; 73(6):565-74. PubMed ID: 27119968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
    Manber R; Buysse DJ; Edinger J; Krystal A; Luther JF; Wisniewski SR; Trockel M; Kraemer HC; Thase ME
    J Clin Psychiatry; 2016 Oct; 77(10):e1316-e1323. PubMed ID: 27788313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does mindfulness-based cognitive therapy with tapering support reduce risk of relapse/recurrence in major depressive disorder by enhancing positive affect? A secondary analysis of the PREVENT trial.
    Dunn BD; Warbrick L; Hayes R; Montero-Marin J; Reed N; Dalgleish T; Kuyken W
    J Consult Clin Psychol; 2024 Sep; 92(9):619-629. PubMed ID: 39418459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Rogier A; Donders T; Speckens AE
    Br J Psychiatry; 2016 Apr; 208(4):366-73. PubMed ID: 26892847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
    Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
    BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
    Furey ML; Drevets WC
    Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does mindfulness-based cognitive therapy work?
    Kuyken W; Watkins E; Holden E; White K; Taylor RS; Byford S; Evans A; Radford S; Teasdale JD; Dalgleish T
    Behav Res Ther; 2010 Nov; 48(11):1105-12. PubMed ID: 20810101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial.
    Driessen E; Van HL; Don FJ; Peen J; Kool S; Westra D; Hendriksen M; Schoevers RA; Cuijpers P; Twisk JW; Dekker JJ
    Am J Psychiatry; 2013 Sep; 170(9):1041-50. PubMed ID: 24030613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
    Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
    Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
    Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
    J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.
    Segal ZV; Walsh KM
    Curr Opin Psychiatry; 2016 Jan; 29(1):7-12. PubMed ID: 26575299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly controlled diabetes mellitus.
    Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Müller MJ
    BMC Psychiatry; 2013 Aug; 13():206. PubMed ID: 23915015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.